José Baselga, Renowned Oncologist, Dies at 61
José Baselga, Renowned Oncologist, Dies at 61
The cancer researcher and executive vice president of AstraZeneca’s oncology research and development is well known for his role in the development of pivotal breast cancer therapies.
José Baselga, Renowned Oncologist, Dies at 61
José Baselga, Renowned Oncologist, Dies at 61

The cancer researcher and executive vice president of AstraZeneca’s oncology research and development is well known for his role in the development of pivotal breast cancer therapies.

The cancer researcher and executive vice president of AstraZeneca’s oncology research and development is well known for his role in the development of pivotal breast cancer therapies.

cancer therapeutics
Boosting CAR T Cell Therapy for Solid Tumors
Boosting CAR T Cell Therapy for Solid Tumors
The Scientist Creative Services Team in Collaboration with IsoPlexis | Apr 5, 2021
Katie McKenna will discuss how oncolytic viral therapy enhances CAR-T cell killing of cancer cells.
Checking Checkpoints for Treating Cancer
Checking Checkpoints for Treating Cancer
The Scientist Creative Services Team | Mar 31, 2021
Researchers devise strategies to improve checkpoint inhibitor therapy and predict patient response.
Surveillance Gaps: How Cancer Arises
Surveillance Gaps: How Cancer Arises
The Scientist Creative Services Team | Mar 15, 2021
Surveillance Gaps: How Cancer Arises
Bispecific Antibodies Treat Cancer in Mouse Models
Bispecific Antibodies Treat Cancer in Mouse Models
Abby Olena | Mar 5, 2021
A trio of papers shows that specialized antibodies can direct T cells to destroy cells that display portions of mutant cancer-related proteins, as well as T cells that have become cancerous themselves.
Perfecting Dose Response Assays
Perfecting Dose Response Assays
The Scientist Creative Services Team | Feb 4, 2021
Jeffrey Weidner and Eric Niederkofler will discuss strategies for optimizing dose response assays.
Blocking Cancer Progression and Shrinking Tumors with Antibody-ligand Traps
Blocking Cancer Progression and Shrinking Tumors with Antibody-ligand Traps
The Scientist Creative Services Team | Dec 4, 2020
LuZhe Sun will discuss TGFβ signaling during cancer progression and how researchers can target this pathway.
The Structure and Functions of the p53 Pathway: Information Acquisition, Redundancy, and Connectivity
The Structure and Functions of the p53 Pathway: Information Acquisition, Redundancy, and Connectivity
The Scientist Creative Services Team | Jun 5, 2020
Arnold Levine will discuss his discovery of p53 and the evolution of the field since then, and Jon Chen will discuss the use of single-cell phosphoproteomics in identifying changes in key signaling networks, including p53.
Infographic: Exercise’s Anticancer Mechanisms
Infographic: Exercise’s Anticancer Mechanisms
Bente Klarlund Pedersen | Apr 1, 2020
A look at the molecular processes that may feed into the tumor-fighting effects of physical activity
CRISPR Quashes Cancer in Mice
CRISPR Quashes Cancer in Mice
Rachael Moeller Gorman | Apr 1, 2020
Gene editing can knock out genes crucial to cervical tumor cells’ survival, researchers report.